520-26-3

Basic information

• Product Name: Hesperidin
• Synonyms: (s)-7-[[6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl]oxy]-2,3-dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4h-1-benzopyran-4-one;VITAMIN P;7-(2-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyloxy)-2,3-dihydro-4',5,7-trihydroxyflavone;7-[[2-O-(6-Deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl]oxy]-5-hydroxy-2(S)-(4-hydroxyphenyl)-4H-1-benzopyran-4-one;CITRUS-HESPERIDIN;HESPERITIN-7-RUTINOSIDE;HESPERIDIN;HESPERIDINE
• CAS NO: 520-26-3
• Molecular Formula: C₂₈H₃₄O₁₅
• Molecular Weight: 610.56
• EINECS: 208-288-1
• Product Categories: Flavanones;plant extract;Antioxidant;Biochemistry;Disaccharides;Flavonoids;Glycosides;Sugars;Natural Plant Extract;Carbohydrates & Derivatives;Intermediates & Fine Chemicals;Pharmaceuticals;chemical reagent;pharmaceutical intermediate;phytochemical;reference standards from Chinese medicinal herbs (TCM).;standardized herbal extract;natural product;Inhibitors
• Mol File: 520-26-3.mol
• Article Data: 5

Chemical Properties

• Melting Point: 250-255 °C (dec.)(lit.)
• Boiling Point: 576.16°C (rough estimate)
• Flash Point: 305.542 °C
• Appearance: light brown/Powder
• Density: 1.3290 (rough estimate)
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.5940 (estimate)
• Storage Temp.: 2-8°C
• Solubility: DMSO (Slightly), Pyridine (Slightly, Sonicated)
• PKA: 7.15±0.40(Predicted)
• Water Solubility: Insoluble in water. Soluble in organic solvents such as DMSO.
• Sensitive: Hygroscopic
• Stability: Stable. Incompatible with strong oxidizing agents.
• Merck: 14,4671
• BRN: 75140
• CAS DataBase Reference: Hesperidin(CAS DataBase Reference)
• NIST Chemistry Reference: Hesperidin(520-26-3)
• EPA Substance Registry System: Hesperidin(520-26-3)

Safety Data

• Hazard Codes: Xi
• Statements: 22-36/37/38
• Safety Statements: 22-24/25-36/37/39-27-26
• WGK Germany: 3
• RTECS: MK6650000
• F: 3-10
• TSCA: Yes
• Hazardous Substances Data: 520-26-3(Hazardous Substances Data)

Usage

Hesperidin

Hesperidin (glycoside) is a flavonoid substance which has flavanone oxygen glycoside structure. It is weakly acidic with pure being white needle-like crystals. It is also the main component of vitamin P. Figure 1 the molecular structure of hesperidin. After the hydrogenation, hesperidin becomes a natural sweetener, dihydrochalcone, whose sweetness is 1,000 times as high as sucrose. It can be used as a functional food for application. Hesperidin has a variety of biological characteristics. Modern research has found that: hesperidin has various effects such as antioxidant, anti-cancer, anti-mildew, anti-allergy, lowering blood pressure, inhibiting oral cancer and esophageal cancer, maintenance of osmotic pressure, increasing capillary toughness, and lowering cholesterol. Related studies have shown that hesperidin has broad antibacterial spectrum on common food contamination. It has significant inhibitory effect on Bacillus subtilis, Salmonella typhimurium, Shigella bacteria, hemolytic streptococcus and Vibrio cholerae. Therefore, it is widely applied in food additives and food processing.

Pharmacological activity

1. Hesperidin is a kind of drug for treatment of hypertension and myocardial infarction. It is used as the pharmaceutical raw material in the pharmaceutical industry and is one of the main components of a Chinese patent medicine, beniol. 2. Hesperidin has various effects such as anti-lipid oxidation, scavenging oxygen free radicals, and anti-inflammatory, anti-viral, anti-bacterial. Long-term use can delay aging and cancer. In short, hesperidin is a kind of flavonoids with clear defined pharmacological activity as well as extensive function of flavonoids. In addition to its application in medicine, it also has wide application in sports pharmacy and sports nutrition and therefore has broad prospects of development and utilization. Its related research work is expected to subject to further deepening.

Industry Status

Hesperidin has various effects such as maintaining osmotic pressure, increasing capillary toughness, shortening the bleeding time, and reducing the cholesterol. It is clinically used for the adjuvant treatment of cardiovascular diseases. It can be used for cultivating various kinds of drugs for preventing arteriosclerosis and myocardial infarction. It is one of the major raw materials for synthesizing Chinese patent medicine “beniol”. It can be used as natural antioxidants in the food industry and can also be used in the cosmetics industry. Hesperidin is mostly presented in the waste of citrus processing such as fruit skin and fruit bag with the highest content being presented in mature skin and tissue (30%-50% in the peel, orange envelope, nuclear, pulp contains 30%-50%, epicarp contains 10%-20%). Orange juice and capsule contain a relative low amount being 1% to 5%. Extraction methods of hesperidin include solvent extraction, alkaline extraction and acid precipitation, carbon adsorption, ion exchange, wherein the alkali extraction and acid precipitation method is simple, low-cost, and has a high extraction rate. Hesperidin can be dissolved in dilute alkali and pyridine as well as hot water (over 70 °C). It is also slightly soluble in methanol but almost insoluble in acetone, benzene and chloroform. The extraction of hesperidin mainly take advantage of its two phenolic hydroxyl groups which under alkaline conditions, has reaction with the sodium ion in the solution to generate sodium salt to be dissolved out; then acidify, cool to precipitate it from solution. Extraction of hesperidin from citrus peels commonly adopts heat extraction and soaks extraction method with a non-idea yield. In recent years, studies on the ultrasonic extraction of the effective components from natural plants (especially herbs) have been widely carried out, and have already obtained some progress. The extraction is first based on the hesperidins’ ring-opening dissolution under alkaline conditions and then further loop closure precipitation for being separated out under acidic conditions. During the extraction process, increasing the amount of the alkali can reduce the necessary amount of ethanol. But it is not recommended to apply a relative large amount of alkaline otherwise hesperidin is easily susceptible to oxidation damage. Figure 2 Yellow powder of hesperidin The above information is edited by the lookchem of Dai Xiongfeng.

Chemical Properties

Different sources of media describe the Chemical Properties of 520-26-3 differently. You can refer to the following data:
1. It is light yellow crystalline powder with melting point being 258-262 °C (soften at 252 °C). It is easily soluble in pyridine, sodium hydroxide solution; soluble in dimethyl formamide; slightly soluble in methanol and hot glacial acetic acid; very slightly soluble in ether, acetone, chloroform and benzene.1g of this product can be dissolved in 50L water. It is odorless and tasteless.
2. light brown powder

Uses

Different sources of media describe the Uses of 520-26-3 differently. You can refer to the following data:
1. The product is a vitamin P type medicine. It is mainly used to enhance the toughness of capillaries. The derivative of hesperidin, methyl hesperidin is also vitamin P type medicine. It has been listed in as a variety in Japan's《Japanese Standard of food additives》. It is a vitamin drug which can reduce the fragility of capillary used for the adjuvant treatment of hypertension.
2. vitamin P is considered a vascular protector and an anti-inflammatory agent, vitamin P is said to promote capillary health and increase resistance to collagen destruction. Vitamin P is a bioflavonoid that can work in conjunction with vitamin C, helping prevent oxidation of the latter. Vitamin P is found in such food sources as apricots, broccoli, citrus fruit pulp, grapes, prunes, and spinach.
3. Hesperidin is a flavoring agent that is a bioflavonoid found in citrus pulp. it has minor use as a flavorant.
4. A flavanone found in citrus fruits, also regarded as Vitamin P.
5. antiinflammatory, capillary protectant, hypolipidemic
6. Anticancer

Production method

The product is presented in the pericarp of lemon, citrus, and Citus aurantium. In citrus, the developed system of the mesocarp (white spongy tissue) mostly contains citrus glycosides.。 Instead thinner system of mesocarp mostly contains hesperidin. The product is mainly extracted from the dried, ripe orange peel. Crush the dry orange peel; add 3-6 times the amount of water to soak for about 0.5h to make it soft. Then add 4-10% of the amount of lime and 7-12 times the amount of water; stir uniformly and check the pH. The pH value should reach 11.5-12, otherwise we should supplement lime or sodium hydroxide. After soaking for 1.5-2h, centrifuge and filter with the residues adding 5-7 times the amount of water and further adjust to pH 11.5-12 with proper amount of lime; continue soaking and centrifuge and filter again. After the clarification of the filtrate, add diluted hydrochloric acid for adjusting pH to 5; stand for 2d; collect the precipitate and wash with water to nearly neutral which give the crude product. Add 1% of sodium hydroxide and 50% of ethanol to dissolve the crude product; filter and adjust the filtrate to pH 5 with dilute hydrochloric acid, stand overnight, and collect the precipitate; first wash once with 50% ethanol, and then wash with water to nearly neutral; dry at 70 °C; pulverize and sieve to obtain hesperidin with the total yield being 0.6-1.8%.

Description

Different sources of media describe the Description of 520-26-3 differently. You can refer to the following data:
1. Hesperidin exists mainly in the peel of lemon, orange, and Seville orange flower, which belong to facilitating medicine. These Chinese medicines are warm and fragrant with the function of eliminating depression and knots. They cure abdominal distension, belching swallow acid pain, nausea and vomiting, diarrhea or constipation caused by the spleen, and stomach qi zhi; and they also cure depression, hernia, breast pain, and menoxenia caused by liver qi; moreover, they cure chest pain, cough, and asthma, which are caused by lung qi. Modern research has shown that li qi medicines have an extensive effect, such as regulatory effect on the digestive system, and they control the bronchial smooth muscle, the uterus smooth muscle, and the cardiovascular system. The base of the effect of li qi medicines in inverse, anti-nausea, antidiarrheal, and analgesia pharmacological effects is its effect in inhibiting gastric bowel movement; its exciting gastrointestinal movement is the foundation to eliminate swelling; its effect in relaxation of the bronchial smooth muscle is the foundation of pharmacological effects in antinausea. The intravenous injection to treat shock effect is the new development of li qi medicine.
2. Hesperidin is a flavanone rutinoside first isolated from citrus peels. It is metabolized by intestinal bacteria to an aglycone form, hesperetin (Item No. 10006084), which is thought to be more bioavailable due to reduced polarity that allows for increased cell permeability. At 100 μM, hesperidin has been shown to increase the cytotoxicity of doxorubicin on MCF-7 and HeLa cancer cells in vitro by inhibiting cell cycle progression and upregulating apoptosis. It also is reported to produce estrogenic effects, decreasing serum and hepatic lipid concentrations and reducing osteoporosis in ovariectomized rats. Hesperidin produces free radical scavenging activity in various in vitro antioxidant assays.

Physical properties

Appearance: fine dendritic crystal (precipitation at pH 6–7), odorless, tasteless. Melting point: 258–262?°C (softening at 250?°C). Solubility: 1?g of hesperidin can be soluble in 50?l of water. Hesperidin dissolves in dimethyl formamide and formamide at 60?°C.?It is slightly soluble in methanol and hot ice acetic acid and hardly soluble in acetone, benzene, and chloroform and is soluble in dilute alkali and pyridine.

History

Hesperidin is the glycoside in the form of hesperidin and rubiose and is a derivative of dihydroflavonoids. It widely exists in legume, birch, lip flower, butterfly flower, Rutaceae, and citrus plants. Hesperidin is an important composition of citrus pulp and peel; most of hesperidin exists in citrus processing waste such as skin and fruit bag. Mature skin and tissue have the highest content of hesperidin (30–50% in endocarp; 30–50% in orange collaterals, nuclear, and pulp; and 10–20% in exo_x005fcarp); the content of hesperidin is relatively low in juice and orange bag, which is about 1–5%. The crude extracts of hesperidin was first discovered in 1827 by Lebreton. Then the Hungarian scholar Albert Szent-Gyorgi discovered that the flavonoids have a protective microvascular effect in 1936, which is similar to that of vitamin P. Preparation of vitamin P was made in 1938. It was not until 1949 that it was discovered that vitamin P was made up of two flavonoids, luteolin and hesperidin, which are believed to be vitamin active. This substance, which was later named as vitamin P, was designed to reduce blood vessel permeability and brittleness, as well as alleviate bad blood and vitamin C deficiency. It was later discovered that the substance had an antioxidant effect, so the name of vitamin P was abandoned. Due to the widespread distribution of hesperidin in plant medicine, the research and development have been widely followed.

Definition

ChEBI: A disaccharide derivative that consists of hesperetin substituted by a 6-O-(alpha-L-rhamnopyranosyl)-beta-D-glucopyranosyl moiety at position 7 via a glycosidic linkage.

Indications

Hesperidin can be used for cardiovascular disease prevention and treatment, blood sugar and blood lipid and blood pressure regulation, circulatory system regulation, and body regulation, and it can also be used as an antibacterial, anti-inflammatory, and antiviral.

Flammability and Explosibility

Nonflammable

Pharmacology

The pharmacological effect of hesperidin is widespread, and people thought it was vitamin P in the early days, but in recent years, people found that it has other functions such as controlling blood pressure, antiallergic, reducing bone mineral density and cholesterol, improving enzyme activity and microcirculation, antibacterial, anti-inflammatory, anti-hepatitis B, antitumor, and other pharmacological effects.Hesperidin has the function of vitamin P, which can reduce capillary permeability and prevent microvascular hemorrhage. Intraperitoneal injection of hesperidin at 175–250?mg/kg in mice could increase permeability of blood vessels by antihistamine and inhibiting hemolytic lecithin. Hesperidin has antiviral and antimicrobial effect, and preincubation with hesperidin at 200? mg/ml protects the cells from viruses. One to 10?μg/ml of hesperidin effectively inhibits the growth of the fungus. It has the effect of maintaining the normal osmotic pressure of the blood vessels, reducing the shortness of blood vessels, shortening bleeding time, reducing blood fat, and preventing atherosclerosis; hesperidin has an effect on the gastrointestinal tract, which can excite the smooth muscle transiently and then inhibit it, and it is a major component of the diet drug; hesperidin has an effect of anti-lipid peroxidation and scavenging hydroxyl radical. Hesperidin is a newly discovered flavonoid compound which has an effect in the central nervous system; it has a sedative effect. At the same time, hesperidin has the effect of lowering cholesterol, curing rheumatism, and inhibiting skin pigmentation. Hesperidin is a strong affinity for estrogen receptors, which can be used in estrogen receptors to prevent bone loss and reduce the number of osteoblasts. Hesperidin has a significant inhibitory effect on human lung cancer, colorectal cancer, kidney cancer, and human breast cancer cells, which can be used for cancer prevention.

Clinical Use

Hesperidin has the effect to maintain osmotic pressure, strengthen the capillary toughness, shorten the bleeding time, lower cholesterol, and so on. Although hesperidin cannot be used as independent medication, it is recorded in the pharmacopoeia that hesperidin, as auxiliary materials, is widely used to aid in the treatment of cardiovascular system; it can be configured as a variety of drugs to prevent hardening of the arteries and myocardial infarction. It is one of the main raw materials of medicine “pulse.” Hesperidin is used as auxiliary materials for the treatment of vascular brittleness, bedsore, rheumatoid arthritis, vitamin C deficiency disease, trauma, obstetric disease, gum inflammation, edema, and gastrointestinal tract disease in the world. Hesperidin can be used to produce an anticancer drug called diosmin. Natural antioxidant is available in the food industry. It is also used in the cosmetics industry.

Purification Methods

Dissolve hesperidine in dilute aqueous alkali and precipitate it by adjusting the pH to 6-7. [Beilstein 18 III/IV 3219, 18/5 V 218.]

InChI:InChI=1/C28H34O15/c1-10-21(32)23(34)25(36)27(40-10)39-9-19-22(33)24(35)26(37)28(43-19)41-12-6-14(30)20-15(31)8-17(42-18(20)7-12)11-3-4-16(38-2)13(29)5-11/h3-7,10,17,19,21-30,32-37H,8-9H2,1-2H3/t10?,17-,19?,21-,22+,23-,24-,25?,26?,27+,28+/m0/s1

Synthetic route

ethanol (64-17-5) + 3,2',6'-trihydroxy-4-methoxy-4'-(O6-α-L-rhamnopyranosyl-β-D-glucopyranosyloxy)-trans-chalcone (50376-44-8) → hesperidin (520-26-3)

Conditions	Yield
at 22℃; Kinetics; pH 3 bis pH 8;

N,N,N',N'-tetramethyl-para-phenylenediamine (100-22-1) + hesperidin radical → N,N,N',N'-tetramethyl-para-semiquinonediimine (100-22-1) + hesperidin (520-26-3)

Conditions	Yield
at 20℃; Equilibrium constant; pH=3.0;
at 20℃; Rate constant; Equilibrium constant; pH=13.5;

hesperidin radical + 10-[2-(dimethylamino)propyl]phenothiazine (60-87-7) → promethazine cation radical (60-87-7, 67253-23-0, 73745-50-3, 92998-17-9) + hesperidin (520-26-3)

Conditions	Yield
at 20℃; Equilibrium constant; pH=3.0;
at 20℃; Rate constant; Equilibrium constant; pH=3;

hesperetin + hexa-O-acetyl-α-rutinosyl bromide → hesperidin (520-26-3)

Conditions	Yield
With quinoline; silver(l) oxide anschl. mit wss.-aethanol. NaOH;

4G-α-D-glucopyranosyl hesperidin (161713-86-6) → hesperidin (520-26-3)

Conditions	Yield
With small intestine homogenate of rat at 37℃; for 1h;

4G-α-D-glucopyranosyl hesperidin (161713-86-6) → hesperidin (520-26-3) + hesperetin (520-33-2)

Conditions	Yield
With small intestine homogenate of rat at 37℃; for 4h; Title compound not separated from byproducts.;

(2S)-7-[[6-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranosyl]oxy]-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-2,3-dihydro-4H-1-benzopyran-4-one (64726-90-5) → (R)-hesperidin (369593-42-0) + hesperidin (520-26-3)

Conditions	Yield
With triethylamine In methanol at 40℃; Kinetics; Temperature; Reagent/catalyst;

hesperidin → (R)-hesperidin (369593-42-0) + hesperidin (520-26-3)

Conditions	Yield
In methanol; formic acid; acetonitrile at 20℃; Resolution of racemate;

hesperidin (520-26-3) → hesperetin (520-33-2)

Conditions	Yield
With sulfuric acid; acetic acid In water for 12h; Reflux;	98%
With sulfuric acid In water at 121℃; for 4h; High pressure;	87%
With sulfuric acid In ethanol for 8h; Reflux;	87%

hesperidin (520-26-3) → diosmin (520-27-4)

Conditions	Yield
With iodine In pyridine at 90℃; for 10h;	89%
With morpholine; iodine at 40 - 70℃; Temperature; Reagent/catalyst; Large scale; Green chemistry;	85.7%
With ethanol; iodine; sodium acetate

hesperidin (520-26-3) → neohesperidin dihydrochalcone

Conditions	Yield
With potassium hydroxide; hydrogen; palladium on activated charcoal at 30℃; under 2280 Torr; for 0.5h;	80%

ammonium hexafluorophosphate + cis-dichloridobis(1,10-phenanthroline)ruthenium(II) + water (7732-18-5) + hesperidin (520-26-3) → cis-[Ru(1,10-phenanthroline)2(hesperidin)](PF6)*2H2O

Conditions	Yield
Stage #1: cis-dichloridobis(1,10-phenanthroline)ruthenium(II); hesperidin With triethylamine In ethanol; water for 8h; Inert atmosphere; Reflux; Stage #2: ammonium hexafluorophosphate; water In ethanol at 0℃;	80%

hesperidin (520-26-3) → hesperidin 2'',2''',3'',3''',4'',4'''-O-hexasulfate

Conditions	Yield
Stage #1: hesperidin With triethylamine sulfurtrioxide In N,N-dimethyl acetamide at 65℃; Stage #2: With triethylamine In N,N-dimethyl acetamide; acetone at 4℃; for 24h; Stage #3: With sodium acetate In water	70%

1,10-Phenanthroline (66-71-7) + magnesium(II) acetate tetrahydrate (16674-78-5) + hesperidin (520-26-3) → cis-[Mg(hesperidin)2(1,10′-phenanthroline)]*2H2O

Conditions	Yield
With triethylamine In methanol for 1h; Inert atmosphere; Reflux;	65%

2,2,2-trifluoroethylbutyrate (371-27-7) + hesperidin (520-26-3) → 3''-O-butanoylhesperidin (131981-33-4)

Conditions	Yield
With pyridine at 45℃; for 48h; subtilisin;	45%

7-hydroxy-4-methyl-chromen-2-one (90-33-5, 79566-13-5) + hesperidin (520-26-3) → 4-methylumbelliferyl-rutinoside (1356391-89-3) + hesperetin (520-33-2)

Conditions	Yield
With water In dimethyl sulfoxide at 30℃; for 1h; pH=5; aq. buffer; Enzymatic reaction;	A 28% B n/a

hesperidin (520-26-3) → hesperetin (520-33-2) + 3′,5,7,8-tetrahydroxy-4′-methoxyflavanone

Conditions	Yield
With Aspergillus saitoi In water; dimethyl sulfoxide at 30℃; pH=5.0;	A n/a B 3.5%

diazomethane (186581-53-3, 908094-01-9) + hesperidin (520-26-3) → homoesperetin-7-O-rutinoside (28034-80-2)

Conditions	Yield
With methanol; diethyl ether

diazomethane (186581-53-3, 908094-01-9) + hesperidin (520-26-3) → 2'-hydroxy-3,4,6'-trimethoxy-4'-(O6-α-L-rhamnopyranosyl-β-D-glucopyranosyloxy)-trans-chalcone (122087-66-5)

Conditions	Yield
With diethyl ether; N,N-dimethyl-formamide

acetic anhydride (108-24-7) + hesperidin (520-26-3) → octa-O-acetylhesperidin (25227-16-1)

Conditions	Yield
With sodium acetate
With pyridine
With pyridine for 24h; Ambient temperature;	96 mg

dimethyl sulfate (77-78-1) + hesperidin (520-26-3) → 4'-hydroxy-3,4,2',6'-tetramethoxy-trans-chalcone (97080-86-9)

Conditions	Yield
With sodium hydroxide Erhitzen des Reaktionsprodukts mit wss.-methanol.H2SO4;

dimethyl sulfate (77-78-1) + hesperidin (520-26-3) → homoesperetin-7-O-rutinoside (28034-80-2)

Conditions	Yield
With sodium hydroxide
With calcium hydroxide
With sodium hydroxide

dimethyl sulfate (77-78-1) + hesperidin (520-26-3) → (S)-2-(3,4-dimethoxy-phenyl)-5-hydroxy-7-(O2-methyl-O6-α-L-rhamnopyranosyl-β-D-glucopyranosyloxy)-chroman-4-one (28719-19-9)

Conditions	Yield
With sodium hydroxide
With calcium hydroxide

dimethyl sulfate (77-78-1) + hesperidin (520-26-3) → (S)-2-(3,4-dimethoxy-phenyl)-5-hydroxy-7-[O2-methyl-O6-(O2-methyl-α-L-rhamnopyranosyl)-β-D-glucopyranosyloxy]-chroman-4-one (28719-20-2)

Conditions	Yield
With sodium hydroxide
With calcium hydroxide

dimethyl sulfate (77-78-1) + hesperidin (520-26-3) → 2'-hydroxy-3,4,6'-trimethoxy-4'-(O2-methyl-O6-α-L-rhamnopyranosyl-β-D-glucopyranosyloxy)-trans-chalcone (122703-82-6)

Conditions	Yield
With sodium hydroxide

dimethyl sulfate (77-78-1) + hesperidin (520-26-3) → (S)-2-(3,4-dimethoxy-phenyl)-5-methoxy-7-(O6-α-L-rhamnopyranosyl-β-D-glucopyranosyloxy)-chroman-4-one (28719-21-3)

Conditions	Yield
With sodium hydroxide

dimethyl sulfate (77-78-1) + hesperidin (520-26-3) → 3,4,2',6'-tetramethoxy-4'-(O2,O3-dimethyl-O6-α-L-rhamnopyranosyl-β-D-glucopyranosyloxy)trans-chalcone (119926-08-8)

Conditions	Yield
With sodium hydroxide; isopropyl alcohol

dimethyl sulfate (77-78-1) + hesperidin (520-26-3) → 3,4,2',6'-tetramethoxy-4'-[O2,O3,O4-trimethyl-O6-(tri-O-methyl-α-L-rhamnopyranosyl)-β-D-glucopyranosyloxy]-trans-chalcone (122703-84-8)

Conditions	Yield
With sodium hydroxide Erwaermen des Reaktionsprodukts mit Methyljodid und Silberoxid;

hesperidin (520-26-3) + propoxycarbonyl chloride (109-61-5) → (Ξ)-5-hydroxy-2-(4-methoxy-3-propoxycarbonyloxy-phenyl)-7-(O6-α-L-rhamnopyranosyl-β-D-glucopyranosyloxy)-chroman-4-one

Conditions	Yield
With sodium hydroxide

hesperidin (520-26-3) + methyl iodide (74-88-4) → 4'-hydroxy-3,4,2',6'-tetramethoxy-trans-chalcone (97080-86-9)

Conditions	Yield
With potassium carbonate; acetone Erhitzen des Reaktionsprodukts mit wss.-methanol.H2SO4;

hesperidin (520-26-3) → Hesperetin chalcone (75679-30-0)

Conditions	Yield
With sulfuric acid; acetic anhydride erhitzen mit wss.Aethanol und Schwefelsaeure;

hesperidin (520-26-3) → isoferulic acid (537-73-5, 1135-16-6, 25522-33-2)

Conditions	Yield
With barium dihydroxide Hydrolysis;

hesperidin (520-26-3) → 5,7,3'-trihydroxy-4'-methoxyl flavanone 7-O-glucoside (2500-68-7, 31712-49-9, 56086-32-9, 67337-82-0)

Conditions	Yield
With formic acid; cyclohexanol

hesperidin (520-26-3) → 3,2',6'-trihydroxy-4-methoxy-4'-(O6-α-L-rhamnopyranosyl-β-D-glucopyranosyloxy)-trans-chalcone (50376-44-8)

Conditions	Yield
With potassium hydroxide

hesperidin (520-26-3) → (3,5-diacetoxy-phenyl)-[O2,O3,O4-triacetyl-O6-(tri-O-acetyl-α-L-rhamnopyranosyl)-β-D-glucopyranoside

Conditions	Yield
With barium dihydroxide; nitrogen; water Erwaermen des Reaktionsprodukts mit Acetanhydrid und Pyridin;

hesperidin (520-26-3) → (S)-2,3-dihydro-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-benzopyrone (520-33-2) + hesperetin (520-33-2)

Conditions	Yield
With sulfuric acid; ethylene glycol
With sulfuric acid
With methanol; sulfuric acid

hesperidin (520-26-3) → hesperidin radical

Conditions	Yield
With singlet oxygen In water at 20℃; Rate constant;
With dibromide radical anion In water Rate constant;

Upstream product

• 100-22-1 N,N,N',N'-tetramethyl-para-phenylenediamine 
• 60-87-7 10-[2-(dimethylamino)propyl]phenothiazine 
• 64726-90-5 (2S)-7-[[6-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranosyl]oxy]-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-2,3-dihydro-4H-1-benzopyran-4-one 
• 161713-86-6 4^G-α-D-glucopyranosyl hesperidin 
• 64-17-5 ethanol 
• 50376-44-8 3,2',6'-trihydroxy-4-methoxy-4'-(O⁶-α-L-rhamnopyranosyl-β-D-glucopyranosyloxy)-trans-chalcone 

Downstream Products

• 131981-33-4 3''-O-butanoylhesperidin 
• 161713-86-6 4^G-α-D-glucopyranosyl hesperidin 
• 2280-44-6 D-Glucose 
• 73-34-7 L-rhamnose 
• 520-33-2 hesperetin 
• 184239-14-3 C₁₃H₂₄O₁₀ 
• 168172-05-2 C₁₅H₂₈O₁₀ 
• 1356391-89-3 4-methylumbelliferyl-rutinoside 
• 187539-57-7 ethyl α-L-rhamnopyranosyl-(1→6)-β-D-glucopyranoside 
• 189187-99-3 C₁₇H₃₂O₁₀ 
• 1174639-57-6 C₁₅H₂₈O₁₀ 
• 26184-96-3 rutinose 
• 6014-42-2 L-rhamnose 
• 88510-10-5 1′-O-benzyl-α-L-rhamnopyranosyl-(1″→6′)-β-D-glucopyranoside 

Relevant articles and documents

Preparation and evaluation of a triazole-bridged bis(β-cyclodextrin)–bonded chiral stationary phase for HPLC

A triazole-bridged bis(β-cyclodextrin) was synthesized via a high-yield Click Chemistry reaction between 6-azido-β-cyclodextrin and 6-propynylamino-β-cyclodextrin, and then it was bonded onto ordered silica gel SBA-15 to obtain a novel triazole-bridged bis (β-cyclodextrin)–bonded chiral stationary phase (TBCDP). The structures of the bridged cyclodextrin and TBCDP were characterized by the infrared spectroscopy, mass spectrometry, elemental analysis, and thermogravimetric analysis. The chiral performance of TBCDP was evaluated by using chiral pesticides and drugs as probes including triazoles, flavanones, dansyl amino acids and β-blockers. Some effects of the composition in mobile phase and pH value on the enantioseparations were investigated in different modes. The nine triazoles, eight flavanones, and eight dansyl amino acids were successfully resolved on TBCDP under the reversed phase with the resolutions of hexaconazole, 2′-hydroxyflavanone, and dansyl-DL-tyrosine, which were 2.49, 5.40, and 3.25 within 30 minutes, respectively. The ten β-blockers were also separated under the polar organic mode with the resolution of arotinolol reached 1.71. Some related separation mechanisms were discussed preliminary. Compared with the native cyclodextrin stationary phase (CDSP), TBCDP has higher enantioselectivity to separate more analytes, which benefited from the synergistic inclusion ability of the two adjacent cavities and bridging linker of TBCDP, thereby enabling it a promising prospect in chiral drugs and food analysis.

Bioavailability of glucosyl hesperidin in rats

Glucosyl hesperidin (G-hesperidin) is a water-soluble derivative of hesperidin. We compared the absorption and metabolism of G-hesperidin with those of hesperidin in rats. After oral administration of G-hesperidin or hesperidin to rats, hesperetin was detected in sera hydrolyzed with β-glucuronidase, but it was not detectable in unhydrolyzed sera. Serum hesperetin was found more rapidly in rats administered G-hesperidin than in those administered hesperidin. The area under the concentration-time curve for hesperetin in the sera of rats administered G-hesperidin was approximately 3.7-fold greater than that of rats administered hesperidin. In the urine of both administration groups, hesperetin and its glucuronide were found. Urinary excretion of metabolites was higher in rats administered G-hesperidin than in those administered hesperidin. These results indicate that G-hesperidin presents the same metabolic profile as hesperidin. Moreover, it was concluded that G-hesperidin is absorbed more rapidly and efficiently than hesperidin, because of its high water solubility.

Conversion of hesperidin into hesperetin

An improved procedure for the conversion of commercial hesperidin into high-purity, crystalline hesperetin is disclosed. This procedure comprises purifying the crude starting material by insolubles removal and precipitation, followed by cleaving the saccharides with a strong mineral acid in lower primary alkanol. The use of lower alkanol in this transformation facilitates the isolation of a high purity product uncontaminated by resinified sugars.